Showing results (1701-1710 of 2,081) with videos related to

Sort By:
Pageof 209
Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.
British Journal of Haematology|June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapyUmar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Haematologica|June 16, 2018
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangementsEllen D McPhail, Matthew J Maurer, William R Macon, et al.
Cancer|March 20, 2014
Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvementErnest T Hawk, Elizabeth B Habermann, Jean G Ford, et al.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
The American Journal of Pathology|May 17, 2020
High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer PatientsAyla Koçak, Kerstin Heselmeyer-Haddad, Annette Lischka, et al.
Current Biology : CB|May 12, 2009
HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integritySteffen Lawo, Mikhail Bashkurov, Michael Mullin, et al.
Blood|February 21, 2012
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphomaYvette L Kasamon, Heather A Jacene, Christopher D Gocke, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Contemporary Clinical Trials|October 1, 2016
The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA TrialRuth Schübel, Mirja E Graf, Johanna Nattenmüller, et al.
Pageof 209